Lev Pharmaceuticals Appoints Vice President

Quote
Well the rumor mill has it that SH (first name rhymes with Druanne)resigned today to join JT at LEV. What in the hell could he possibly want her there for, she did nothing at OraPharma?!! (Besides get drunk off her ass and fall down and mumble alot in front of A.M.'s, who were "junior" to her, real professional. How did she survive at Ora and get promoted? Slllllllllurrrrrrrrp. Fact is stranger than fiction.
 






Anonymous said:
Well the rumor mill has it that SH (first name rhymes with Druanne)resigned today to join JT at LEV. What in the hell could he possibly want her there for, she did nothing at OraPharma?!! (Besides get drunk off her ass and fall down and mumble alot in front of A.M.'s, who were "junior" to her, real professional. How did she survive at Ora and get promoted? Slllllllllurrrrrrrrp. Fact is stranger than fiction.
Click to expand...

Life at ORA will never be the same. Next you'll tell me that we'll have room mates at meetings and they'll be dry. At least SH and JT were entertaining. Remember when she was in that cast a couple of years ago and he was caught bringing a tray of food up to her room. SIGH...good times.
 
























Anonymous said:
Well the rumor mill has it that SH (first name rhymes with Druanne)resigned today to join JT at LEV. What in the hell could he possibly want her there for, she did nothing at OraPharma?!! (Besides get drunk off her ass and fall down and mumble alot in front of A.M.'s, who were "junior" to her, real professional. How did she survive at Ora and get promoted? Slllllllllurrrrrrrrp. Fact is stranger than fiction.
Click to expand...

Is this confirmed? ROFL!
 


















AWESOME!

Press Release Source: Lev Pharmaceuticals, Inc.


Lev Pharmaceuticals, Inc. Announces Completion of Marketing and Sales Management Team
Tuesday June 26, 9:00 am ET
Company is positioned to build sales force and complete launch preparations
Lead product candidate, C1-INH, to be marketed as Cinryze(TM)


NEW YORK, June 26 /PRNewswire-FirstCall/ -- Lev Pharmaceuticals, Inc. ("Lev" or the "Company") (OTC Bulletin Board: LEVP.OB - News) today announced it has completed the formation of its marketing and sales management team. During the past ten months, Lev has been building its commercial team and is now poised to complete launch preparations, including building a sales force, to support the commercialization of its lead product candidate, C1-esterase inhibitor (C1-INH), to be marketed as Cinryze(TM), for the treatment of hereditary angioedema (HAE), if and when approved by the FDA.
ADVERTISEMENT


"We now have our marketing, reimbursement and sales management team in place and are well positioned to build our sales force and complete launch preparations," said Joe Truitt, Vice President of Sales and Marketing. "We have assembled a very experienced and dynamic commercial team with strong pharmaceutical experience and an impressive track record of success in launching major new products."

Key members of the marketing and sales management team include:

Stephen L. Collins, Executive Director, Distribution and Patient Services. Mr. Collins joined the Company from MedImmune where he last held the position of Senior Director, Managed Care and Customer Operations. Prior to MedImmune, Mr. Collins served as Regional Director of the Managed Care Team for Burroughs Wellcome, a Glaxo SmithKline company.

Paul Firuta, Director, Reimbursement and Managed Care. Mr. Firuta previously served as Director, National Accounts and Reimbursement at OraPharma, a Johnson & Johnson company. Prior to Johnson & Johnson, Mr. Firuta spent nine years at SmithKline Beecham Pharmaceuticals, where he last held the position of Manager, Business Development and Managed Care.

Susanne Heinzinger, Director of Marketing. Previously, Ms. Heinzinger was a Corporate Account Director, Reimbursement for OraPharma, a Johnson & Johnson company. While at OraPharma, Ms. Heinzinger developed and implemented marketing programs for the company's flagship product, ARESTIN®. Prior to Johnson & Johnson, Ms. Heinzinger served as Product Manager at TAP Pharmaceuticals where she worked on the commercial launch for LUPRON DEPOT®.
 




































For any of you that are too new to remember the JT/SH saga, it was sick enough that I occasionally return here to see if it continued. I guess I will always wonder if people truly do get thiers in the end...

Karma=What goes around, comes around.
 






LEV is launching their drug this year. JT in charge of Business Development and SH in charge of Marketing.

Not sure how that entails "getting thiers" (nice spelling by the way).
 






























Top Bottom
Back
Quote